Statistics
Publications
6.4K
Citations
770.9K
Authors
923
Location
Ridgefield, United States
6.4K
923
Boehringer Ingelheim (United States), United States
588 publications · 15.9K citations
68
h-index
65
h-index
Boehringer Ingelheim (United States), United States
143 publications · 20.8K citations
57
h-index
51
h-index
Boehringer Ingelheim (United States), United States
129 publications · 9.3K citations
45
h-index
1–5 of 923
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
Bernard Zinman, Christoph Wanner, John M. Lachin et al. · New England Journal of Medicine · 2015 · 12K citations · Full text
Dabigatran versus Warfarin in Patients with Atrial Fibrillation
Stuart J. Connolly, Michael D. Ezekowitz, Salim Yusuf et al. · New England Journal of Medicine · 2009 · 11.2K citations · Full text
Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure
Milton Packer, Stefan D. Anker, Javed Butler et al. · New England Journal of Medicine · 2020 · 5K citations · Full text
Medicine, Cardiology, Pharmacology +17
Efficacy and Safety of Nintedanib in Idiopathic Pulmonary Fibrosis
Luca Richeldi, Roland M. du Bois, Ganesh Raghu et al. · New England Journal of Medicine · 2014 · 4.6K citations · Full text
Dabigatran versus Warfarin in the Treatment of Acute Venous Thromboembolism
Sam Schulman, Clive Kearon, Ajay K. Kakkar et al. · New England Journal of Medicine · 2009 · 2.6K citations · Full text
1–5 of 6.4K